*ST苏吴: 江苏吴中医药发展股份有限公司第十一届监事会第五次会议决议公告

Core Viewpoint - The supervisory board of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. has approved the company's 2025 semi-annual report, a special report on the use of funds raised from a private placement, and a proposal for the postponement of certain investment projects funded by the raised capital, indicating compliance with relevant laws and regulations [1][2]. Group 1 - The supervisory board confirmed that the 2025 semi-annual report was prepared and reviewed in accordance with the Company Law, Shanghai Stock Exchange listing rules, and other regulations, accurately reflecting the company's operational and financial status for the first half of 2025 [1]. - The voting results for the approval of the semi-annual report were unanimous, with 3 votes in favor, 0 abstentions, and 0 votes against [2]. - The supervisory board also approved a special report on the storage and actual use of funds raised from the private placement, affirming its compliance with relevant laws and regulations [2]. Group 2 - The supervisory board agreed to the postponement of certain investment projects funded by the raised capital, stating that this decision was made after careful analysis and would not harm the interests of the company or its shareholders [2]. - The voting results for the approval of the investment project postponement were also unanimous, with 3 votes in favor, 0 abstentions, and 0 votes against [2].